Michael Marks

16.9k total citations · 3 hit papers
230 papers, 6.2k citations indexed

About

Michael Marks is a scholar working on Infectious Diseases, Epidemiology and Physiology. According to data from OpenAlex, Michael Marks has authored 230 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Infectious Diseases, 80 papers in Epidemiology and 70 papers in Physiology. Recurrent topics in Michael Marks's work include Syphilis Diagnosis and Treatment (68 papers), Reproductive tract infections research (42 papers) and Dermatological diseases and infestations (40 papers). Michael Marks is often cited by papers focused on Syphilis Diagnosis and Treatment (68 papers), Reproductive tract infections research (42 papers) and Dermatological diseases and infestations (40 papers). Michael Marks collaborates with scholars based in United Kingdom, United States and Australia. Michael Marks's co-authors include Oscar Benavente, Jonathan L. Halperin, Karen L. Furie, Lee H. Schwamm, Gregory W. Albers, Robert E. Harbaugh, Margaret Kelly‐Hayes, Irene Katzan, Edgar J. Kenton and Larry B. Goldstein and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Michael Marks

211 papers receiving 6.0k citations

Hit Papers

Guidelines for Prevention of Stroke in Patients With Isch... 2006 2026 2012 2019 2006 2022 2021 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Marks United Kingdom 35 2.3k 1.4k 1.2k 1.1k 952 230 6.2k
William C. Blackwelder United States 48 2.9k 1.3× 1.7k 1.2× 682 0.6× 711 0.7× 346 0.4× 125 8.8k
Jeannette Y. Lee United States 45 1.6k 0.7× 1.0k 0.8× 936 0.8× 292 0.3× 693 0.7× 173 6.3k
Ronald B. Geskus Netherlands 48 2.8k 1.2× 2.2k 1.6× 924 0.8× 560 0.5× 375 0.4× 192 9.1k
Jérémie F. Cohen France 30 1.6k 0.7× 1.5k 1.1× 1.5k 1.3× 478 0.5× 637 0.7× 139 8.9k
Anders Hviid Denmark 40 2.4k 1.0× 1.5k 1.1× 342 0.3× 581 0.5× 326 0.3× 159 6.8k
Frank DeStefano United States 61 4.4k 1.9× 2.7k 2.0× 407 0.3× 1.1k 1.0× 675 0.7× 170 12.2k
M. Miles Braun United States 36 2.8k 1.2× 2.6k 1.9× 428 0.4× 344 0.3× 433 0.5× 79 8.1k
Sotirios Tsiodras Greece 50 2.3k 1.0× 4.1k 3.0× 623 0.5× 356 0.3× 321 0.3× 316 9.7k
Eric Weintraub United States 47 6.9k 3.0× 3.8k 2.7× 519 0.4× 877 0.8× 313 0.3× 176 11.5k
Douglas Fleming United Kingdom 51 5.4k 2.3× 1.4k 1.0× 799 0.7× 269 0.3× 679 0.7× 158 8.0k

Countries citing papers authored by Michael Marks

Since Specialization
Citations

This map shows the geographic impact of Michael Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Marks more than expected).

Fields of papers citing papers by Michael Marks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Marks. The network helps show where Michael Marks may publish in the future.

Co-authorship network of co-authors of Michael Marks

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Marks. A scholar is included among the top collaborators of Michael Marks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Marks. Michael Marks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martin, Kevin, Ethel Dauya, Chido Dziva Chikwari, et al.. (2025). Evaluation of a novel point-of-care lateral flow assay screening for Neisseria gonorrhoeae infection among pregnant women in Zimbabwe. PLOS Global Public Health. 5(2). e0003839–e0003839. 1 indexed citations
2.
Jarju, Sheikh, Alexander J. Keeley, Jennifer Hall, et al.. (2025). Evaluating clinical decision rules and rapid diagnostic tests for the diagnosis of Streptococcus pyogenes pharyngitis in Gambian children: A diagnostic accuracy study. Journal of Infection. 91(2). 106546–106546.
3.
Erausquin, Jennifer Toller, Jacqueline Hendriks, Michael Marks, et al.. (2025). Online health survey research during COVID-19. Publisher.
4.
Jones, Alexis, et al.. (2024). Lyme arthritis: It’s never too late for joint decision making. Clinical Infection in Practice. 25. 100406–100406.
5.
Marley, Gifty, Phyllis Dako‐Gyeke, Elizabeth Chen, et al.. (2024). Collective Intelligence–Based Participatory COVID-19 Surveillance in Accra, Ghana: Pilot Mixed Methods Study. PubMed. 4. e50125–e50125. 1 indexed citations
6.
Keeley, Alexander J., et al.. (2024). Health-seeking behaviour and beliefs around sore throat in The Gambia: A qualitative study. SHILAP Revista de lepidopterología. 4(3). e0002257–e0002257. 1 indexed citations
7.
Mtuy, Tara, Yaw Ampem Amoako, Michael Marks, et al.. (2024). Stigma experiences, effects and coping among individuals affected by Buruli ulcer and yaws in Ghana. PLoS neglected tropical diseases. 18(4). e0012093–e0012093. 4 indexed citations
8.
Martin, Kevin, Chido Dziva Chikwari, Ethel Dauya, et al.. (2023). Investigating point-of-care diagnostics for sexually transmitted infections and antimicrobial resistance in antenatal care in Zimbabwe (IPSAZ): protocol for a mixed-methods study. BMJ Open. 13(4). e070889–e070889. 4 indexed citations
9.
Amoako, Yaw Ampem, Jacob Novignon, Adwoa Asante-Poku, et al.. (2023). Buruli-RifDACC: Evaluation of the efficacy and cost-effectiveness of high-dose versus standard-dose rifampicin on outcomes in Mycobacterium ulcerans disease, a protocol for a randomised controlled trial in Ghana. SHILAP Revista de lepidopterología. 2. 59–59. 1 indexed citations
10.
McPherson, Scott W., Hiwot Solomon, Biruck Kebede, et al.. (2023). Safety of integrated mass drug administration of azithromycin, albendazole and ivermectin versus standard treatment regimens: a cluster-randomised trial in Ethiopia. EClinicalMedicine. 59. 101984–101984. 3 indexed citations
11.
Doni, Shimelis N., Yohannes Hailemichael, Abebaw Yeshambel Alemu, et al.. (2023). Protocol for a prospective observational cohort study of cutaneous leishmaniasis in Ethiopia. NIHR Open Research. 3. 49–49. 3 indexed citations
12.
Gibbs, Hamish, Anwar Musah, William Ampofo, et al.. (2023). Call detail record aggregation methodology impacts infectious disease models informed by human mobility. PLoS Computational Biology. 19(8). e1011368–e1011368.
13.
Brown, Michael, Megan Plowright, Katie Drury, et al.. (2022). Demographics and Outcomes of Initial Phase of COVID-19 Medicines Delivery Units Across 4 UK Centers During Peak B1.1.529 Omicron Epidemic: A Service Evaluation. Open Forum Infectious Diseases. 9(10). ofac527–ofac527. 2 indexed citations
14.
Gabster, Amanda, Jennifer Toller Erausquin, Kristien Michielsen, et al.. (2021). How did COVID-19 measures impact sexual behaviour and access to HIV/STI services in Panama? Results from a national cross-sectional online survey. Sexually Transmitted Infections. 98(5). 332–340. 16 indexed citations
15.
Marks, Michael, Sarah Gwyn, Christian Kositz, et al.. (2020). Impact of Community Treatment With Ivermectin for the Control of Scabies on the Prevalence of Antibodies to Strongyloides stercoralis in Children. Clinical Infectious Diseases. 71(12). 3226–3228. 11 indexed citations
16.
Gu, Xuefeng, Ying Gao, Yan Yan, et al.. (2020). The importance of proper and prompt treatment of ocular syphilis: a lesson from permanent vision loss in 52 eyes. Journal of the European Academy of Dermatology and Venereology. 34(7). 1569–1578. 29 indexed citations
17.
Kollie, Karsor, Katherine E. Halliday, Rachel L. Pullan, et al.. (2020). The prevalence of scabies in Monrovia, Liberia: A population-based survey. PLoS neglected tropical diseases. 14(12). e0008943–e0008943. 25 indexed citations
18.
Addo, Kennedy Kwasi, et al.. (2019). Optimising the use of molecular tools for the diagnosis of yaws. Transactions of the Royal Society of Tropical Medicine and Hygiene. 113(12). 776–780. 2 indexed citations
19.
Gonçalves, Adriana, Amabélia Rodrigues, Umberto D’Alessandro, et al.. (2019). Perceptions, attitudes and practices towards scabies in communities on the Bijagós Islands, Guinea-Bissau. Transactions of the Royal Society of Tropical Medicine and Hygiene. 114(1). 49–56. 18 indexed citations
20.
Ong, Jason J., Weiming Tang, M. Kumi Smith, et al.. (2019). Risk attitudes, risky sexual behaviours and willingness to test negative for syphilis using lottery-based financial incentives among Chinese men who have sex with men. Sexually Transmitted Infections. 96(5). 355–357. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026